Late blood pressure reduction in SHR subjected to transient captopril treatment in youth: possible mechanisms

Spontaneously hypertensive rats (SHR) are characterized by enhanced nifedipine-sensitive component of sympathetic vasoconstriction. Our study tried to elucidate the mechanisms responsible for long-term reduction of blood pressure (BP) in SHR subjected to early transient captopril treatment. Adult un...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Physiological research 2008-01, Vol.57 (3), p.495-498
Hauptverfasser: Zicha, J, Dobešová, Z, Kunes, J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 498
container_issue 3
container_start_page 495
container_title Physiological research
container_volume 57
creator Zicha, J
Dobešová, Z
Kunes, J
description Spontaneously hypertensive rats (SHR) are characterized by enhanced nifedipine-sensitive component of sympathetic vasoconstriction. Our study tried to elucidate the mechanisms responsible for long-term reduction of blood pressure (BP) in SHR subjected to early transient captopril treatment. Adult untreated SHR aged 30-34 weeks were compared with animals subjected to chronic captopril treatment for 6 weeks either in youth (between 4 and 10 weeks of age) or in adulthood (between 24 and 30 weeks of age). Antihypertensive effects of captopril were more pronounced in young than adult SHR. This was due to greater attenuation of sympathetic and nifedipine-sensitive BP components and prevention of residual BP rise in young captopril-treated SHR in which the reductions of nifedipine-sensitive BP component and residual BP persisted for 20 weeks after captopril withdrawal. The magnitude of nifedipine-sensitive component of sympathetic vasoconstriction is decisive for BP maintenance not only in untreated SHR but also in SHR during active captopril treatment by or after its withdrawal.
doi_str_mv 10.33549/physiolres.931615
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69289470</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1531325741</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-5fe93f5716a7215fc4d6290d39f44a7f6035fdaf57a65a438bbd56e1a65daddf3</originalsourceid><addsrcrecordid>eNpdkU1r3DAQhkVJ6W62_QM9BJFDbk71YX31VpYmG1goNOnZyNaI9WJbjiQf9t9X7S4EchpmeN6XmXkR-krJPeeiNt_mwyn1YYiQ7g2nkooPaE01YZUxil-hNdGSVbomeoWuUzoSwhRR_BNaUS2MElqt0bi3GXA7hODwXIzSEgFHcEuX-zDhfsLPu984Le0RugwO54BztFPqYcq4s3MOc-yHMgObx3-zojiFJR--4zmk1LcD4BG6g536NKbP6KO3Q4Ivl7pBfx5-vmx31f7X49P2x77quGK5Eh4M90JRaRWjwne1k8wQx42va6u8JFx4ZwthpbA1123rhARaOmed83yD7s6-cwyvC6TcjH3qYBjsBGFJjTRMm1qRAt6-A49hiVPZrWGUUSWpNgViZ6iL5aQIvik3jzaeGkqa_0k0b0k05ySK6ObivLQjuDfJ5fX8L2RJieY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>212176189</pqid></control><display><type>article</type><title>Late blood pressure reduction in SHR subjected to transient captopril treatment in youth: possible mechanisms</title><source>MEDLINE</source><source>Free E-Journal (出版社公開部分のみ)</source><source>Directory of Open Access Journals</source><creator>Zicha, J ; Dobešová, Z ; Kunes, J</creator><creatorcontrib>Zicha, J ; Dobešová, Z ; Kunes, J</creatorcontrib><description>Spontaneously hypertensive rats (SHR) are characterized by enhanced nifedipine-sensitive component of sympathetic vasoconstriction. Our study tried to elucidate the mechanisms responsible for long-term reduction of blood pressure (BP) in SHR subjected to early transient captopril treatment. Adult untreated SHR aged 30-34 weeks were compared with animals subjected to chronic captopril treatment for 6 weeks either in youth (between 4 and 10 weeks of age) or in adulthood (between 24 and 30 weeks of age). Antihypertensive effects of captopril were more pronounced in young than adult SHR. This was due to greater attenuation of sympathetic and nifedipine-sensitive BP components and prevention of residual BP rise in young captopril-treated SHR in which the reductions of nifedipine-sensitive BP component and residual BP persisted for 20 weeks after captopril withdrawal. The magnitude of nifedipine-sensitive component of sympathetic vasoconstriction is decisive for BP maintenance not only in untreated SHR but also in SHR during active captopril treatment by or after its withdrawal.</description><identifier>ISSN: 0862-8408</identifier><identifier>EISSN: 1802-9973</identifier><identifier>DOI: 10.33549/physiolres.931615</identifier><identifier>PMID: 18597587</identifier><language>eng</language><publisher>Czech Republic: Institute of Physiology</publisher><subject>Age Factors ; Angiotensin-Converting Enzyme Inhibitors - administration &amp; dosage ; Animals ; Antihypertensive Agents - administration &amp; dosage ; Blood Pressure - drug effects ; Captopril - administration &amp; dosage ; Children &amp; youth ; Disease Models, Animal ; Drug Administration Schedule ; Hypertension ; Hypertension - drug therapy ; Hypertension - physiopathology ; Male ; Nifedipine - pharmacology ; Rats ; Rats, Inbred SHR ; Rodents ; Sympathetic Nervous System - drug effects ; Sympathetic Nervous System - physiopathology ; Vasoconstriction - drug effects ; Vasodilator Agents - pharmacology</subject><ispartof>Physiological research, 2008-01, Vol.57 (3), p.495-498</ispartof><rights>Copyright Institute of Physiology 2008</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-5fe93f5716a7215fc4d6290d39f44a7f6035fdaf57a65a438bbd56e1a65daddf3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18597587$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zicha, J</creatorcontrib><creatorcontrib>Dobešová, Z</creatorcontrib><creatorcontrib>Kunes, J</creatorcontrib><title>Late blood pressure reduction in SHR subjected to transient captopril treatment in youth: possible mechanisms</title><title>Physiological research</title><addtitle>Physiol Res</addtitle><description>Spontaneously hypertensive rats (SHR) are characterized by enhanced nifedipine-sensitive component of sympathetic vasoconstriction. Our study tried to elucidate the mechanisms responsible for long-term reduction of blood pressure (BP) in SHR subjected to early transient captopril treatment. Adult untreated SHR aged 30-34 weeks were compared with animals subjected to chronic captopril treatment for 6 weeks either in youth (between 4 and 10 weeks of age) or in adulthood (between 24 and 30 weeks of age). Antihypertensive effects of captopril were more pronounced in young than adult SHR. This was due to greater attenuation of sympathetic and nifedipine-sensitive BP components and prevention of residual BP rise in young captopril-treated SHR in which the reductions of nifedipine-sensitive BP component and residual BP persisted for 20 weeks after captopril withdrawal. The magnitude of nifedipine-sensitive component of sympathetic vasoconstriction is decisive for BP maintenance not only in untreated SHR but also in SHR during active captopril treatment by or after its withdrawal.</description><subject>Age Factors</subject><subject>Angiotensin-Converting Enzyme Inhibitors - administration &amp; dosage</subject><subject>Animals</subject><subject>Antihypertensive Agents - administration &amp; dosage</subject><subject>Blood Pressure - drug effects</subject><subject>Captopril - administration &amp; dosage</subject><subject>Children &amp; youth</subject><subject>Disease Models, Animal</subject><subject>Drug Administration Schedule</subject><subject>Hypertension</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - physiopathology</subject><subject>Male</subject><subject>Nifedipine - pharmacology</subject><subject>Rats</subject><subject>Rats, Inbred SHR</subject><subject>Rodents</subject><subject>Sympathetic Nervous System - drug effects</subject><subject>Sympathetic Nervous System - physiopathology</subject><subject>Vasoconstriction - drug effects</subject><subject>Vasodilator Agents - pharmacology</subject><issn>0862-8408</issn><issn>1802-9973</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkU1r3DAQhkVJ6W62_QM9BJFDbk71YX31VpYmG1goNOnZyNaI9WJbjiQf9t9X7S4EchpmeN6XmXkR-krJPeeiNt_mwyn1YYiQ7g2nkooPaE01YZUxil-hNdGSVbomeoWuUzoSwhRR_BNaUS2MElqt0bi3GXA7hODwXIzSEgFHcEuX-zDhfsLPu984Le0RugwO54BztFPqYcq4s3MOc-yHMgObx3-zojiFJR--4zmk1LcD4BG6g536NKbP6KO3Q4Ivl7pBfx5-vmx31f7X49P2x77quGK5Eh4M90JRaRWjwne1k8wQx42va6u8JFx4ZwthpbA1123rhARaOmed83yD7s6-cwyvC6TcjH3qYBjsBGFJjTRMm1qRAt6-A49hiVPZrWGUUSWpNgViZ6iL5aQIvik3jzaeGkqa_0k0b0k05ySK6ObivLQjuDfJ5fX8L2RJieY</recordid><startdate>20080101</startdate><enddate>20080101</enddate><creator>Zicha, J</creator><creator>Dobešová, Z</creator><creator>Kunes, J</creator><general>Institute of Physiology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>4U-</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BYOGL</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20080101</creationdate><title>Late blood pressure reduction in SHR subjected to transient captopril treatment in youth: possible mechanisms</title><author>Zicha, J ; Dobešová, Z ; Kunes, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-5fe93f5716a7215fc4d6290d39f44a7f6035fdaf57a65a438bbd56e1a65daddf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Age Factors</topic><topic>Angiotensin-Converting Enzyme Inhibitors - administration &amp; dosage</topic><topic>Animals</topic><topic>Antihypertensive Agents - administration &amp; dosage</topic><topic>Blood Pressure - drug effects</topic><topic>Captopril - administration &amp; dosage</topic><topic>Children &amp; youth</topic><topic>Disease Models, Animal</topic><topic>Drug Administration Schedule</topic><topic>Hypertension</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - physiopathology</topic><topic>Male</topic><topic>Nifedipine - pharmacology</topic><topic>Rats</topic><topic>Rats, Inbred SHR</topic><topic>Rodents</topic><topic>Sympathetic Nervous System - drug effects</topic><topic>Sympathetic Nervous System - physiopathology</topic><topic>Vasoconstriction - drug effects</topic><topic>Vasodilator Agents - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zicha, J</creatorcontrib><creatorcontrib>Dobešová, Z</creatorcontrib><creatorcontrib>Kunes, J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>Nursing &amp; Allied Health Database</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>East Europe, Central Europe Database</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Physiological research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zicha, J</au><au>Dobešová, Z</au><au>Kunes, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Late blood pressure reduction in SHR subjected to transient captopril treatment in youth: possible mechanisms</atitle><jtitle>Physiological research</jtitle><addtitle>Physiol Res</addtitle><date>2008-01-01</date><risdate>2008</risdate><volume>57</volume><issue>3</issue><spage>495</spage><epage>498</epage><pages>495-498</pages><issn>0862-8408</issn><eissn>1802-9973</eissn><abstract>Spontaneously hypertensive rats (SHR) are characterized by enhanced nifedipine-sensitive component of sympathetic vasoconstriction. Our study tried to elucidate the mechanisms responsible for long-term reduction of blood pressure (BP) in SHR subjected to early transient captopril treatment. Adult untreated SHR aged 30-34 weeks were compared with animals subjected to chronic captopril treatment for 6 weeks either in youth (between 4 and 10 weeks of age) or in adulthood (between 24 and 30 weeks of age). Antihypertensive effects of captopril were more pronounced in young than adult SHR. This was due to greater attenuation of sympathetic and nifedipine-sensitive BP components and prevention of residual BP rise in young captopril-treated SHR in which the reductions of nifedipine-sensitive BP component and residual BP persisted for 20 weeks after captopril withdrawal. The magnitude of nifedipine-sensitive component of sympathetic vasoconstriction is decisive for BP maintenance not only in untreated SHR but also in SHR during active captopril treatment by or after its withdrawal.</abstract><cop>Czech Republic</cop><pub>Institute of Physiology</pub><pmid>18597587</pmid><doi>10.33549/physiolres.931615</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0862-8408
ispartof Physiological research, 2008-01, Vol.57 (3), p.495-498
issn 0862-8408
1802-9973
language eng
recordid cdi_proquest_miscellaneous_69289470
source MEDLINE; Free E-Journal (出版社公開部分のみ); Directory of Open Access Journals
subjects Age Factors
Angiotensin-Converting Enzyme Inhibitors - administration & dosage
Animals
Antihypertensive Agents - administration & dosage
Blood Pressure - drug effects
Captopril - administration & dosage
Children & youth
Disease Models, Animal
Drug Administration Schedule
Hypertension
Hypertension - drug therapy
Hypertension - physiopathology
Male
Nifedipine - pharmacology
Rats
Rats, Inbred SHR
Rodents
Sympathetic Nervous System - drug effects
Sympathetic Nervous System - physiopathology
Vasoconstriction - drug effects
Vasodilator Agents - pharmacology
title Late blood pressure reduction in SHR subjected to transient captopril treatment in youth: possible mechanisms
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T06%3A35%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Late%20blood%20pressure%20reduction%20in%20SHR%20subjected%20to%20transient%20captopril%20treatment%20in%20youth:%20possible%20mechanisms&rft.jtitle=Physiological%20research&rft.au=Zicha,%20J&rft.date=2008-01-01&rft.volume=57&rft.issue=3&rft.spage=495&rft.epage=498&rft.pages=495-498&rft.issn=0862-8408&rft.eissn=1802-9973&rft_id=info:doi/10.33549/physiolres.931615&rft_dat=%3Cproquest_cross%3E1531325741%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=212176189&rft_id=info:pmid/18597587&rfr_iscdi=true